Palisade Bio, Inc.
USD1.93
+0.07 (+3.76%)
CEO
J. D. Finley
IPO Date
2007-03-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.88
Prev. Close
$1.86
Day Low
$1.84
Day High
$1.96
52W Low
$0.53
52W High
$2.86
Market Cap
$0.34B
Volume
3.38M
| 8,000 |
| $0.00 |
| 13 Feb 2026 | Jones Mitchell Lawrence | Chief Medical Officer | M-Exempt | Disposed | 8,000 | $0.00 |
| 13 Feb 2026 | Finley John David | director, officer: CEO, CFO | M-Exempt | Acquired | 13,333 | $0.00 |
| 13 Feb 2026 | Finley John David | director, officer: CEO, CFO | S-Sale | Disposed | 3,896 | $1.75 |
| 13 Feb 2026 | Finley John David | director, officer: CEO, CFO | M-Exempt | Disposed | 13,333 | $0.00 |
| 11 Feb 2026 | Jones Mitchell Lawrence | Chief Medical Officer | A-Award | Acquired | 787,000 | $0.00 |
| 11 Feb 2026 | Finley John David | director, officer: CEO, CFO | A-Award | Acquired | 2,011,000 | $0.00 |
| 21 Jan 2026 | Williams Donald Allen | director | P-Purchase | Acquired | 5,000 | $1.67 |
| 13 Jan 2026 | Williams Donald Allen | director | P-Purchase | Acquired | 5,000 | $1.88 |